Feasibility and safety of nintedanib in combination with nivolumab in pretreated patients with advanced or metastatic adenocarcinoma of the lung – An AIO phase Ib/II trial

Lung Cancer 2026

View at publisher
Authors: Martin Reck, Cornelius Florian Waller, Parvis Sadjadian, Karl-Otto Kambartel, Christian Grohé, A. Sendler, Niels Reinmuth, Achim Rittmeyer, Marcos Marin-Galiano, Ralph Wirtz, Markus Eckstein, Ralph Keller
+2 more H. von Suchodoletz, Martin Sebastian
DOI: 10.1016/j.lungcan.2026.109318
Cited by: 0
References: 12

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Diagnosis and Treatment

Publication details

Journal / source
Lung Cancer
Volume
214
Pages
109318–109318
Publication date
12 February 2026
Language
EN